Many reasons exist for undertreatment, but ultimately, in high-risk patients, the clinician needs to discuss the value of maximal LDL-C lowering and utilize regular monitoring for efficacy and adherence. https://t.co/fTjBMlG0pO https://t.co/wgWVSaSsnN
Many reasons exist for undertreatment, but ultimately, in high-risk patients, the clinician needs to discuss the value of maximal LDL-C lowering and utilize regular monitoring for efficacy and adherence. https://t.co/Cxp48b6nJt https://t.co/agG8gqVEfO
Many reasons exist for undertreatment, but ultimately, in high-risk patients, the clinician needs to discuss the value of maximal LDL-C lowering and utilize regular monitoring for efficacy and adherence. https://t.co/4oxJo9cwx8 https://t.co/kVvSFLcx1Z
Many reasons exist for undertreatment, but ultimately, in high-risk patients, the clinician needs to discuss the value of maximal LDL-C lowering and utilize regular monitoring for efficacy and adherence. https://t.co/bXM97rzZsC https://t.co/aA32cFGWA2